An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 202231
Company: FRESENIUS KABI USA

Summary Review

Products on NDA 202231

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	100MCG/VIAL	POWDER;INTRAVENOUS	Prescription	AP	Yes	Yes
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	200MCG/VIAL	POWDER;INTRAVENOUS	Prescription	AP	Yes	Yes
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	500MCG/VIAL	POWDER;INTRAVENOUS	Prescription	AP	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 202231

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/24/2011	ORIG-1	Approval	Type 7 - Drug Already Marketed without Approved NDA	STANDARD	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202231s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/202231s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202231_levothyroxine_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202231Orig1s000Sum.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/04/2014	SUPPL-6	Manufacturing (CMC)		Label is not available on this site.
11/26/2013	SUPPL-5	Manufacturing (CMC)		Label is not available on this site.
02/16/2013	SUPPL-4	Manufacturing (CMC)		Label is not available on this site.
12/20/2012	SUPPL-3	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202231s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202231Orig1s003ltr.pdf

Labels for NDA 202231

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/20/2012	SUPPL-3	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202231s003lbl.pdf
06/24/2011	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202231s000lbl.pdf

Therapeutic Equivalents for NDA 202231

LEVOTHYROXINE SODIUM

POWDER;INTRAVENOUS; 100MCG/VIAL
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	100MCG/VIAL	POWDER;INTRAVENOUS	Prescription	Yes	AP	202231	FRESENIUS KABI USA
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	100MCG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	208749	MAIA PHARMS INC
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	100MCG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	206163	PIRAMAL CRITICAL
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	100MCG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	217495	XIROMED
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	100MCG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	217066	ZYDUS PHARMS

POWDER;INTRAVENOUS; 200MCG/VIAL
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	200MCG/VIAL	POWDER;INTRAVENOUS	Prescription	Yes	AP	202231	FRESENIUS KABI USA
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	200MCG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	208749	MAIA PHARMS INC
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	200MCG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	217066	ZYDUS PHARMS

POWDER;INTRAVENOUS; 500MCG/VIAL
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	500MCG/VIAL	POWDER;INTRAVENOUS	Prescription	Yes	AP	202231	FRESENIUS KABI USA
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	500MCG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	208749	MAIA PHARMS INC
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	500MCG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	206163	PIRAMAL CRITICAL
LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	500MCG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	217066	ZYDUS PHARMS

Top